Capricor Therapeutics Inc (CAPR)
US$ 6.34-9.04%
Price Chart
Key Statistics
Market Cap
$ 289.59M
P/E Ratio
0.00
Revenue (TTM)
$ 22.27M
Volume
3.62M
52W High
$ 23.40
52W Low
$ 3.52
Dividend Yield
0.00%
Beta
0.86
Technicals
50-Day MA
11.4272
200-Day MA
12.4214
52 Week High
23.4
52 Week Low
3.52
About CAPR
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and.
Employees
160
Headquarters
San Diego, CA
CEO
Dr. Frank Isaac Litvack FACC, M.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg